WO2001064227A3 - Androgenic activity of eucommia ulmoides extracts - Google Patents

Androgenic activity of eucommia ulmoides extracts Download PDF

Info

Publication number
WO2001064227A3
WO2001064227A3 PCT/SG2001/000038 SG0100038W WO0164227A3 WO 2001064227 A3 WO2001064227 A3 WO 2001064227A3 SG 0100038 W SG0100038 W SG 0100038W WO 0164227 A3 WO0164227 A3 WO 0164227A3
Authority
WO
WIPO (PCT)
Prior art keywords
present
composition
eucommia ulmoides
modulating
androgenic activity
Prior art date
Application number
PCT/SG2001/000038
Other languages
French (fr)
Other versions
WO2001064227A2 (en
Inventor
Yek Cheng Ong
Eu Leong Yong
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Priority to AU42993/01A priority Critical patent/AU4299301A/en
Publication of WO2001064227A2 publication Critical patent/WO2001064227A2/en
Publication of WO2001064227A3 publication Critical patent/WO2001064227A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates generally to a method for modulating steroidogenic activity and a composition useful for same. The present invention further relates to a composition comprising a steroidogenic modulator useful for modulating physiological processes mediated by the androgen receptor or an active form thereof or complex comprising same and/or for modulating physiological processes mediated by estrogen receptors. The composition of the present invention preferably comprises an extract of herbs or botanical or horticultural equivalents of the herbs or chemical or functional equivalents of one or more components of the herbal extract thereof.
PCT/SG2001/000038 2000-02-29 2001-02-27 Androgenic activity of eucommia ulmoides extracts WO2001064227A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU42993/01A AU4299301A (en) 2000-02-29 2001-02-27 A method for modulating steroidogenic activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18575700P 2000-02-29 2000-02-29
US60/185,757 2000-02-29

Publications (2)

Publication Number Publication Date
WO2001064227A2 WO2001064227A2 (en) 2001-09-07
WO2001064227A3 true WO2001064227A3 (en) 2002-04-04

Family

ID=22682344

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SG2001/000038 WO2001064227A2 (en) 2000-02-29 2001-02-27 Androgenic activity of eucommia ulmoides extracts

Country Status (3)

Country Link
US (2) US6905714B2 (en)
AU (1) AU4299301A (en)
WO (1) WO2001064227A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132117B2 (en) * 2000-08-29 2006-11-07 Government Of Malaysia Bioactive fraction of Eurycoma longifolia
US7524518B2 (en) * 2001-05-11 2009-04-28 Kim Sung-Jin Composition for promoting regeneration of hard tissues comprising an extract of cortex eucommiae
TWI221154B (en) * 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect
US7381432B2 (en) * 2006-09-19 2008-06-03 Jose Angel Olalde Menopause disorder synergistic phyto-nutraceutical composition
JP2009091276A (en) * 2007-10-05 2009-04-30 Pola Chem Ind Inc Composition for bone ageing inhibition
US7893399B2 (en) * 2008-09-09 2011-02-22 Quest Diagnostics Investments Incorporated Methods for detecting dehydroepiandrosterone by mass spectrometry
US7804063B2 (en) * 2008-10-06 2010-09-28 Quest Diagnostics Investments Incorporated Methods for detecting dihydrotestosterone by mass spectrometry
CN102885726A (en) * 2011-07-19 2013-01-23 上海家化联合股份有限公司 Eucommia extract product, its preparation method and application thereof
CN104391072B (en) * 2014-11-12 2016-08-17 广州白云山敬修堂药业股份有限公司 A kind of detection method of the compound Chinese medicinal preparation treating osteoporosis
US11058737B2 (en) * 2018-10-29 2021-07-13 Biotropics Malaysia Berhad Use of Euycoma longifolia extract in alleviating symptoms and/or conditions associated with hormonal imbalance in females
CN111804004B (en) * 2020-08-03 2021-07-20 于瀛 Extraction and leaching method of traditional Chinese medicine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04169536A (en) * 1990-10-30 1992-06-17 Morishita Jintan Kk Therapeutic agent for osteoporosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04187623A (en) * 1990-11-22 1992-07-06 Pola Chem Ind Inc Hair cosmetics
JPH05268921A (en) * 1992-03-25 1993-10-19 Hitachi Zosen Corp Blend of 'tochu' tea with roast tea
US6017924A (en) * 1996-06-27 2000-01-25 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04169536A (en) * 1990-10-30 1992-06-17 Morishita Jintan Kk Therapeutic agent for osteoporosis

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL & PHARMACEUTICAL BULLETIN, vol. 17, no. 7, 1994, pages 917 - 920, ISSN: 0918-6158 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1994, METORI KOICHI ET AL: "Effects of Du-Zhong leaf extract on serum and hepatic lipids in rats fed a high-fat diet.", XP002184764, Database accession no. PREV199598097079 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1997, QU GANG-JIAN ET AL: "Anabolic effects of Tu-Chung extract. Studies using castrated rat.", XP002184762, Database accession no. PREV199799662861 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; August 1999 (1999-08-01), QU GANG-JIAN ET AL: "Effects of Tu-Chung extract administrating on serum testosterone in hindlimb-suspended rats.", XP002184763, Database accession no. PREV200000057941 *
JAPANESE JOURNAL OF PHYSICAL FITNESS AND SPORTS MEDICINE, vol. 46, no. 3, 1997, pages 263 - 272, ISSN: 0039-906X *
PATENT ABSTRACTS OF JAPAN vol. 016, no. 470 (C - 0990) 30 September 1992 (1992-09-30) *
TAIRYOKU KAGAKU, vol. 48, no. 4, August 1999 (1999-08-01), pages 501 - 508, ISSN: 0039-906X *

Also Published As

Publication number Publication date
AU4299301A (en) 2001-09-12
US20050123634A1 (en) 2005-06-09
WO2001064227A2 (en) 2001-09-07
US20010046524A1 (en) 2001-11-29
US6905714B2 (en) 2005-06-14

Similar Documents

Publication Publication Date Title
WO2001064227A3 (en) Androgenic activity of eucommia ulmoides extracts
EP1779729A3 (en) Synergistic and residual pesticidal compositions containing plant essential oils
DE60000259D1 (en) GREEN TEA EXTRACTS CONTAINING CATECHOLE AND CAFFEINE
EP1407679A4 (en) Process for producing plant extract containing plant powder
AU2002231544A1 (en) Therapeutic uses of herbal compositions
WO2008001325A3 (en) Herbal compositions for the treatment of diseases of the oral cavity
Jin Study on antioxidant activities of extracts from different parts of Korean and Iranian pomegranates
WO2003020860A3 (en) Methods for treating deodorizer distillate
WO2002067886A3 (en) Skin composition
MY137752A (en) Medicament for treating aseptic inflammations containing anemonin as effective component
HUP0200173A2 (en) Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne
EP1192938A3 (en) Composition to enhance permeation of topical skin agents
DE60117606D1 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF HEADACHE DISORDERS
WO2002092042A3 (en) Pharmaceutical and cosmetic compositions against skin aging
WO1998053678A3 (en) Means amd method for pest control
CA2242419A1 (en) Stable perfumed bleaching compositions
ES2176786T3 (en) USE OF GINKGO BILOBA EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS.
WO1999059523A3 (en) Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis
EP1550667A4 (en) Tyrosinase activity controlling agents, process for producing the same and external preparations containing the same
WO2002003973A3 (en) Compositions comprising isosorbide dinitrate and methods for treatment of anal fissure
DE60030786D1 (en) MURRAYA KOENIGII EXTRACTS FOR THE TREATMENT OF ASTHMA
DK0824356T3 (en) Pharmaceutical compositions for the treatment of alcohol dependence
EP1228690A4 (en) Insecticide compositions and method for destroying insects
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
WO2003086566A3 (en) Method and device for obtaining plant ingredients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CN JP NZ SG

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CN JP NZ SG

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP